A mathematical model of the impact of present and future malaria vaccines

BackgroundWith the encouraging advent of new malaria vaccine candidates, mathematical modelling of expected impacts of present and future vaccines as part of multi-intervention strategies is especially relevant.MethodsThe impact of potential malaria vaccines is presented utilizing the EMOD model, a comprehensive model of the vector life cycle coupled to a detailed mechanistic representation of intra-host parasite and immune dynamics. Values of baseline transmission and vector feeding behaviour parameters are identified, for which local elimination is enabled by layering pre-erythrocytic vaccines of various efficacies on top of high and sustained insecticide-treated net coverage. The expected reduction in clinical cases is further explored in a scenario that targets children by adding a pre-erythrocytic vaccine to the EPI programme for newborns.ResultsAt high transmission, there is a minimal reduction in clinical disease cases, as the time to infection is only slightly delayed. At lower transmission, there is an accelerating community-level protection that has subtle dependences on heterogeneities in vector behaviour, ecology, and intervention coverage. At very low transmission, the trend reverses as many children are vaccinated to prevent few cases.ConclusionsThe maximum-impact setting is one in which the impact of increasing bed net coverage has saturated, vector feeding is primarily outdoors, and transmission is just above the threshold where small perturbations from a vaccine intervention result in large community benefits.

[1]  Thomas A. Smith,et al.  Modeling a field trial of the RTS,S/AS02A malaria vaccine. , 2006, The American journal of tropical medicine and hygiene.

[2]  A. Bennett,et al.  Barriers to Insecticide-Treated Mosquito Net Possession 2 Years after a Mass Free Distribution Campaign in Luangwa District, Zambia , 2010, PloS one.

[3]  G. Killeen,et al.  Short report: entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa. , 1999, The American journal of tropical medicine and hygiene.

[4]  David L. Smith,et al.  Travel risk, malaria importation and malaria transmission in Zanzibar , 2011, Scientific reports.

[5]  M. Fay,et al.  Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51 , 2008, PloS one.

[6]  Joel D. Selanikio,et al.  Sustained high coverage of insecticide‐treated bednets through combined Catch‐up and Keep‐up strategies , 2007, Tropical medicine & international health : TM & IH.

[7]  J. Sachs,et al.  A global index representing the stability of malaria transmission. , 2004, The American journal of tropical medicine and hygiene.

[8]  I. Sherman.  Molecular approaches to malaria , 2005 .

[9]  John M. Miller,et al.  Determinants of hanging and use of ITNs in the context of near universal coverage in Zambia. , 2012, Health policy and planning.

[10]  J. Baird,et al.  A biologic basis for integrated malaria control. , 2002, The American journal of tropical medicine and hygiene.

[11]  J Hemingway,et al.  Insecticide resistance in insect vectors of human disease. , 2000, Annual review of entomology.

[12]  Thomas Smith,et al.  Ensemble Modeling of the Likely Public Health Impact of a Pre-Erythrocytic Malaria Vaccine , 2012, PLoS medicine.

[13]  David L Smith,et al.  Revisiting the Basic Reproductive Number for Malaria and Its Implications for Malaria Control , 2007, PLoS biology.

[14]  W. Ballou,et al.  Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data , 2009, Malaria Journal.

[15]  D. Conway,et al.  Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial , 2001, The Lancet.

[16]  J. Dushoff,et al.  The entomological inoculation rate and Plasmodium falciparum infection in African children , 2005, Nature.

[17]  Rifat Atun,et al.  Effect of Investment in Malaria Control on Child Mortality in Sub-Saharan Africa in 2002–2008 , 2011, PloS one.

[18]  Kevin Marsh,et al.  Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria , 1998, Nature Medicine.

[19]  Tanya L Russell,et al.  Increased proportions of outdoor feeding among residual malaria vector populations following increased use of insecticide-treated nets in rural Tanzania , 2011, Malaria Journal.

[20]  Chris J Drakeley,et al.  Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials , 2010, Malaria Journal.

[21]  D. Cole,et al.  Spatial Distribution of Bednet Coverage under Routine Distribution through the Public Health Sector in a Rural District in Kenya , 2011, PloS one.

[22]  K. Mendis,et al.  Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential , 1991, The Journal of experimental medicine.

[23]  M E Halloran,et al.  Modeling malaria vaccines. I: New uses for old ideas. , 1989, Mathematical biosciences.

[24]  S. Kyes,et al.  Molecular aspects of antigenic variation in Plasmodium falciparum. , 2005 .

[25]  Q. Bassat,et al.  Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial , 2005, The Lancet.

[26]  J. Botella de Maglia,et al.  [Prevention of malaria]. , 1999, Revista clinica espanola.

[27]  S. Kyes,et al.  Antigenic Variation in Plasmodium falciparum Malaria Involves a Highly Structured Switching Pattern , 2011, PLoS pathogens.

[28]  K. Silamut,et al.  Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.

[29]  Fredros O. Okumu,et al.  Consistently high estimates for the proportion of human exposure to malaria vector populations occurring indoors in rural Africa , 2013, International journal of epidemiology.

[30]  A. Githeko,et al.  Insecticide-treated net (ITN) ownership, usage, and malaria transmission in the highlands of western Kenya , 2011, Parasites & Vectors.

[31]  R. Snow,et al.  Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. , 1999, Bulletin of the World Health Organization.

[32]  Inacio Mandomando,et al.  Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial , 2004, The Lancet.

[33]  Simon I. Hay,et al.  Stable and Unstable Malaria Hotspots in Longitudinal Cohort Studies in Kenya , 2010, PLoS medicine.

[34]  M. Demoitié,et al.  Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. , 2008, The New England journal of medicine.

[35]  R. Snow,et al.  A climate-based distribution model of malaria transmission in sub-Saharan Africa. , 1999, Parasitology today.

[36]  R. Sauerwein,et al.  Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. , 2007, The American journal of tropical medicine and hygiene.

[37]  Amanda Ross,et al.  Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: Overview. , 2006, The American journal of tropical medicine and hygiene.

[38]  David L. Smith,et al.  Quantifying the Impact of Human Mobility on Malaria , 2012, Science.

[39]  A. Holder,et al.  Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. , 1999, Parassitologia.

[40]  Marcel Tanner,et al.  Integrated urban malaria control: a case study in dar es salaam, Tanzania. , 2004, The American journal of tropical medicine and hygiene.

[41]  Tanya L Russell,et al.  Human exposure to anopheline mosquitoes occurs primarily indoors, even for users of insecticide-treated nets in Luangwa Valley, South-east Zambia , 2012, Parasites & Vectors.

[42]  R. Sinden,et al.  Plasmodium falciparum gametocytes: their longevity and infectivity , 1977, Parasitology.

[43]  P. Eckhoff.  A malaria transmission-directed model of mosquito life cycle and ecology , 2011, Malaria Journal.

[44]  Teun Bousema,et al.  Hitting Hotspots: Spatial Targeting of Malaria for Control and Elimination , 2012, PLoS medicine.

[45]  G. Killeen,et al.  The potential impact of integrated malaria transmission control on entomologic inoculation rate in highly endemic areas. , 2000, The American journal of tropical medicine and hygiene.

[46]  L. Molineaux,et al.  The Garki project: Research on the epidemiology and control of malaria in the Sudan savanna of West Africa , 1980 .

[47]  S. P. Kachur,et al.  Preventing Childhood Malaria in Africa by Protecting Adults from Mosquitoes with Insecticide-Treated Nets , 2007, PLoS medicine.

[48]  Stephen S. Lim,et al.  Net Benefits: A Multicountry Analysis of Observational Data Examining Associations between Insecticide-Treated Mosquito Nets and Health Outcomes , 2011, PLoS medicine.

[49]  J. Sattabongkot,et al.  Plasmodium vivax Ookinete Surface Protein Pvs25 Linked to Cholera Toxin B Subunit Induces Potent Transmission-Blocking Immunity by Intranasal as Well as Subcutaneous Immunization , 2010, Infection and Immunity.

[50]  Pedro Alonso,et al.  First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. , 2011, The New England journal of medicine.

[51]  K. Mendis,et al.  Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. , 1993, Immunology.

[52]  R. Sinden,et al.  Regulation of infectivity of Plasmodium to the mosquito vector. , 1996, Advances in parasitology.

[53]  J. Kihonda,et al.  Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission. , 1993, Acta tropica.

[54]  David L. Smith,et al.  A new world malaria map: Plasmodium falciparum endemicity in 2010 , 2011, Malaria Journal.

[55]  J. Trape.  The public health impact of chloroquine resistance in Africa. , 2001, The American journal of tropical medicine and hygiene.

[56]  P. Carnevale,et al.  Influence of deltamethrin treatment of bed nets on malaria transmission in the Kou valley, Burkina Faso. , 1991, Bulletin of the World Health Organization.

[57]  M. Littrell,et al.  Assessment of insecticide-treated bednet use among children and pregnant women across 15 countries using standardized national surveys. , 2009, The American journal of tropical medicine and hygiene.

[58]  G. Macdonald,et al.  Theory of the eradication of malaria. , 1956, Bulletin of the World Health Organization.

[59]  M. Gillies.,et al.  The effect of a residual house-spraying campaign in East Africa on species balance in the Anopheles funestus group. The replacement of A. funestus Giles by A. rivulorum Leeson. , 1960 .

[60]  P. Eckhoff,et al.  Mathematical Models of Within-Host and Transmission Dynamics to Determine Effects of Malaria Interventions in a Variety of Transmission Settings , 2013, The American journal of tropical medicine and hygiene.

[61]  Wes Hinsley,et al.  Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies , 2010, PLoS medicine.

[62]  C. Drakeley,et al.  The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. , 2006, Trends in parasitology.

[63]  D E EYLES,et al.  Infectivity to mosquitoes of Plasmodium falciparum as related to gametocyte density and duration of infection. , 1955, The American journal of tropical medicine and hygiene.

[64]  J. Vanderberg,et al.  Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei , 1967, Nature.

[65]  R. Feachem,et al.  Shrinking the Malaria Map: A Prospectus on Malaria Elimination , 2009 .

[66]  P. Eckhoff,et al.  Malaria parasite diversity and transmission intensity affect development of parasitological immunity in a mathematical model , 2012, Malaria Journal.

[67]  S. Hay,et al.  The global distribution of clinical episodes of Plasmodium falciparum malaria , 2005, Nature.

[68]  P. Eckhoff,et al.  P. falciparum Infection Durations and Infectiousness Are Shaped by Antigenic Variation and Innate and Adaptive Host Immunity in a Mathematical Model , 2012, PloS one.

[69]  T. Wilkes,et al.  Trial of pyrethroid impregnated bednets in an area of Tanzania holoendemic for malaria. Part 2. Effects on the malaria vector population. , 1991, Acta tropica.

[70]  Fabrizio Tediosi,et al.  Simulation of the cost-effectiveness of malaria vaccines , 2009, Malaria Journal.

[71]  Nicolas Maire,et al.  What Should Vaccine Developers Ask? Simulation of the Effectiveness of Malaria Vaccines , 2008, PloS one.

[72]  K. Matuschewski,et al.  Vaccines against malaria – an update , 2007, The FEBS journal.

[73]  David L. Smith,et al.  A World Malaria Map: Plasmodium falciparum Endemicity in 2007 , 2009, PLoS medicine.

[74]  W. Ballou.  The development of the RTS,S malaria vaccine candidate: challenges and lessons , 2009, Parasite immunology.

[75]  Amanda Ross,et al.  A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas. , 2006, The American journal of tropical medicine and hygiene.

[76]  Kwaku Poku Asante,et al.  Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data , 2013, The Lancet. Infectious diseases.

[77]  J. Sattabongkot,et al.  Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. , 2005, Vaccine.